Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.
Condition(s):SLE (Systemic Lupus)Last Updated:February 12, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):SLE (Systemic Lupus)Last Updated:February 12, 2024Recruiting
Condition(s):CMV InfectionLast Updated:March 10, 2020Completed
Condition(s):LeukemiaLast Updated:April 4, 2022Not yet recruiting
Condition(s):Melanoma; Melanoma, Uveal; Head and Neck CancerLast Updated:December 4, 2023Recruiting
Condition(s):Relapse Multiple Myeloma; Refractory Multiple MyelomaLast Updated:December 17, 2020Not yet recruiting
Condition(s):Chronic Graft vs Host DiseaseLast Updated:May 26, 2022Recruiting
Condition(s):Glioma; Malignant Glioma of Brain; Recurrence TumorLast Updated:June 15, 2021Unknown status
Condition(s):Lymphoma, Large-Cell, Anaplastic; Enteropathy-Associated T-Cell Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell, PeripheralLast Updated:January 18, 2023Completed
Condition(s):Leukemia, B-cellLast Updated:January 17, 2024Not yet recruiting
Condition(s):Solid and Hematological MalignanciesLast Updated:January 7, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.